Statins in liver disease: not only prevention of cardiovascular events

Antonio Magan-Fernandez; Manfredi Rizzo; Giuseppe Montalto; Giulio Marchesini

doi:10.1080/17474124.2018.1477588

Statins in liver disease: not only prevention of cardiovascular events

Expert Rev Gastroenterol Hepatol. 2018 Aug;12(8):743-744. doi: 10.1080/17474124.2018.1477588. Epub 2018 May 24.

Authors

Antonio Magan-Fernandez^{1

2}, Manfredi Rizzo¹, Giuseppe Montalto¹, Giulio Marchesini³

Affiliations

¹ a Biomedical Department of Internal Medicine and Medical Specialties , University of Palermo , Palermo , Italy.
² b Department of Periodontology, School of Dentistry , University of Granada , Granada , Spain.
³ c Dipartimento di Scienze Mediche e Chirurgiche, 'Alma Mater Studiorum' , University of Bologna , Bologna , Italy.

PMID: 29768950
DOI: 10.1080/17474124.2018.1477588

No abstract available

Keywords: Fatty liver; cardiovascular risk; drug safety; fatty liver; hydroxymethylglutaryl-CoA reductase inhibitors; non-alcoholic fatty liver disease.

Publication types

Editorial
Review

MeSH terms

Cardiovascular Diseases / etiology
Cardiovascular Diseases / prevention & control*
Disease Progression
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hypolipidemic Agents / therapeutic use*
Non-alcoholic Fatty Liver Disease / complications
Non-alcoholic Fatty Liver Disease / drug therapy*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents